When it comes to questionable marketing and billing practices for lab testing, clinical laboratory companies can expect increased scrutiny and enforcement actions by federal healthcare authorities. That's one message in a recently issued white paper that was jointly authored by[…]
A new study, now published in the journal Nature Biotechnology, posits that people who are at a high risk of heart disease due to their excessive levels of cholesterol may soon have a safe and effective alternative treatment in gene[…]
EPFL scientists have discovered two small-molecule compound series that can effectively block a central pathway of the innate immune system, offering a promising new way for treating autoinflammatory diseases. The study is published in Nature.